20% Tilmicosin Premix
.png)
.png)
.png)
.png)
Pharmacological action
Tilmicosin is a macrolide antibiotic, has inhibitory effect on gram-positive bacteria, some gram-negative bacteria, mycoplasma, spirochetes, etc.; it has stronger antibacterial activity than tylosin against Actinomyces pleuropneumoniae and Pasteurella. It is used in veterinary medicine for the treatment of bovine respiratory disease and enzootic pneumonia caused by Mannheimia (Pasteurella) haemolytica in sheep.
Product Features
Tilmicosin Premix has a strong inhibitory effect on a variety of bacteria and mycoplasma. It can significantly improve the immunity of the animal body, and has a specific and obvious relieving effect on various symptoms caused by high fever diseases.
1.Instead of tylosin, it is the drug of choice for the prevention and treatment of respiratory tract infections in chickens
2. Improve the body's ability to resist high fever diseases, relieve the symptoms of high fever diseases, and purify circovirus and PRRS positive farms.
3. Treatment of Haemophilus parasuis, infectious pleuropneumonia, asthma, atrophic rhinitis.
Product Features
4. Advanced enteric-coated technology, gradually released in the intestine absorption
5. High drug concentration in the lungs, good tissue penetration, long half-life
6. Choose the latest solid dispersion technology
7. Good palatability, which is conducive to feeding
Indications
Swine: Mycoplasma pneumonia, asthma, infectious pleuropneumonia, Haemophilus disease, streptococcal pneumonia, ileitis, colitis, mycoplasma arthritis and other diseases have a good effect;
Poultry: Mycoplasma-induced chronic respiratory diseases, fowl cholera, bronchitis, laryngotracheitis, airsacculitis, mycoplasmosis, colibacillosis, respiratory transmission, egg drop syndrome caused by respiratory diseases in eggs. It can effectively control chicken respiratory disease syndrome (cough, sneeze, bronchitis, rales), air sacculitis, sinusitis, synovitis and other diseases caused by Mycoplasma septicemia, Mycoplasma synovialis, and E. coli, and effectively solve chicken mortality Increase or decrease in weight gain and other issues.
Dosage and Administration
Treatment dosage: Mix 100g of this product with 200kg of water,
Prevention dosage: Mix 100g of this product with 300kg of water
Once a day, double for the first time, used for 3-5 days
Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation based veterinary enterprise, there are 65 technical professionals. Veyong has two production bases: Shijiazhuang and Ordos, of which the Shijiazhuang base covers an area of 78,706 m2, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 11 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own- label preparations, and OEM & ODM service.
Veyong attaches great importance to the management of EHS(Environment, Health& Safety) system, and obtained the ISO14001 and OHSAS18001 certificates. Veyong has been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply of products.
Veyong established the complete quality management system, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technical service, our company has gained reliance and support from numerous customers by excellent product quality, high-quality pre-sales and after-sales service, serious and scientific management. Veyong has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.
